date,title,source
Oct-17-18,"New Research Coverage Highlights Esperion Therapeutics, Summit Therapeutics, Ocwen Financial, Keane Group, Cellectis S.A, and Rapid7  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-18-18,Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),GlobeNewswire
Oct-26-18,"Today's Research Reports on Trending Tickers: Gilead Sciences, Inc. and Esperion Therapeutics, Inc.",ACCESSWIRE
Oct-29-18,Esperion stock surges 15% on late-stage results for cholesterol drug,MarketWatch
Oct-31-18,Esperion CEO on safety of new cholesterol drug,CNBC Videos
